These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 39043345)

  • 1. SARS-CoV-2 S1 subunit produces a protracted priming of the neuroinflammatory, physiological, and behavioral responses to a remote immune challenge: A role for corticosteroids.
    Frank MG; Ball JB; Hopkins S; Kelley T; Kuzma AJ; Thompson RS; Fleshner M; Maier SF
    Brain Behav Immun; 2024 Oct; 121():87-103. PubMed ID: 39043345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 spike S1 subunit induces neuroinflammatory, microglial and behavioral sickness responses: Evidence of PAMP-like properties.
    Frank MG; Nguyen KH; Ball JB; Hopkins S; Kelley T; Baratta MV; Fleshner M; Maier SF
    Brain Behav Immun; 2022 Feb; 100():267-277. PubMed ID: 34915155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The redox state of the alarmin HMGB1 is a pivotal factor in neuroinflammatory and microglial priming: A role for the NLRP3 inflammasome.
    Frank MG; Weber MD; Fonken LK; Hershman SA; Watkins LR; Maier SF
    Brain Behav Immun; 2016 Jul; 55():215-224. PubMed ID: 26482581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 Spike Protein S1 Exposure Increases Susceptibility to Angiotensin II-Induced Hypertension in Rats by Promoting Central Neuroinflammation and Oxidative Stress.
    Sun Q; Li L; Jin F; Liu Y; Yang B; Meng W; Zhang Z; Qi F
    Neurochem Res; 2023 Oct; 48(10):3016-3026. PubMed ID: 37269471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute stress induces chronic neuroinflammatory, microglial and behavioral priming: A role for potentiated NLRP3 inflammasome activation.
    Frank MG; Fonken LK; Watkins LR; Maier SF
    Brain Behav Immun; 2020 Oct; 89():32-42. PubMed ID: 32485293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrin drives thromboinflammation and neuropathology in COVID-19.
    Ryu JK; Yan Z; Montano M; Sozmen EG; Dixit K; Suryawanshi RK; Matsui Y; Helmy E; Kaushal P; Makanani SK; Deerinck TJ; Meyer-Franke A; Rios Coronado PE; Trevino TN; Shin MG; Tognatta R; Liu Y; Schuck R; Le L; Miyajima H; Mendiola AS; Arun N; Guo B; Taha TY; Agrawal A; MacDonald E; Aries O; Yan A; Weaver O; Petersen MA; Meza Acevedo R; Alzamora MDPS; Thomas R; Traglia M; Kouznetsova VL; Tsigelny IF; Pico AR; Red-Horse K; Ellisman MH; Krogan NJ; Bouhaddou M; Ott M; Greene WC; Akassoglou K
    Nature; 2024 Sep; 633(8031):905-913. PubMed ID: 39198643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the immunogenic properties of SARS-CoV-2 structural proteins: PAMP:TLR signaling in the mediation of the neuroinflammatory and neurologic sequelae of COVID-19.
    Frank MG; Fleshner M; Maier SF
    Brain Behav Immun; 2023 Jul; 111():259-269. PubMed ID: 37116592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of Exaggerated Cytokine Production in Human Peripheral Blood Mononuclear Cells by a Recombinant SARS-CoV-2 Spike Glycoprotein S1 and Its Inhibition by Dexamethasone.
    Olajide OA; Iwuanyanwu VU; Lepiarz-Raba I; Al-Hindawi AA
    Inflammation; 2021 Oct; 44(5):1865-1877. PubMed ID: 33860869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of Serum Cross-Reactive Antibodies and Memory Response to SARS-CoV-2 in Prepandemic and Post-COVID-19 Convalescent Samples.
    Shrwani K; Sharma R; Krishnan M; Jones T; Mayora-Neto M; Cantoni D; Temperton NJ; Dobson SL; Subramaniam K; McNamara PS; Cunliffe NA; Turtle L; Zhang Q
    J Infect Dis; 2021 Oct; 224(8):1305-1315. PubMed ID: 34161567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
    Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM
    Elife; 2022 Jan; 11():. PubMed ID: 35072628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 Spike Glycoprotein S1 Induces Neuroinflammation in BV-2 Microglia.
    Olajide OA; Iwuanyanwu VU; Adegbola OD; Al-Hindawi AA
    Mol Neurobiol; 2022 Jan; 59(1):445-458. PubMed ID: 34709564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resolvin D1 and D2 reduce SARS-CoV-2-induced inflammatory responses in cystic fibrosis macrophages.
    Recchiuti A; Patruno S; Mattoscio D; Isopi E; Pomilio A; Lamolinara A; Iezzi M; Pecce R; Romano M
    FASEB J; 2021 Apr; 35(4):e21441. PubMed ID: 33749902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection.
    Patterson BK; Francisco EB; Yogendra R; Long E; Pise A; Rodrigues H; Hall E; Herrera M; Parikh P; Guevara-Coto J; Triche TJ; Scott P; Hekmati S; Maglinte D; Chang X; Mora-Rodríguez RA; Mora J
    Front Immunol; 2021; 12():746021. PubMed ID: 35082777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limited Variation between SARS-CoV-2-Infected Individuals in Domain Specificity and Relative Potency of the Antibody Response against the Spike Glycoprotein.
    Van Ert HA; Bohan DW; Rogers K; Fili M; Rojas Chávez RA; Qing E; Han C; Dempewolf S; Hu G; Schwery N; Sevcik K; Ruggio N; Boyt D; Pentella MA; Gallagher T; Jackson JB; Merrill AE; Knudson CM; Brown GD; Maury W; Haim H
    Microbiol Spectr; 2022 Feb; 10(1):e0267621. PubMed ID: 35080430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development.
    Kim E; Erdos G; Huang S; Kenniston TW; Balmert SC; Carey CD; Raj VS; Epperly MW; Klimstra WB; Haagmans BL; Korkmaz E; Falo LD; Gambotto A
    EBioMedicine; 2020 May; 55():102743. PubMed ID: 32249203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective Inhibition of the Interaction between SARS-CoV-2 Spike S1 and ACE2 by SPIDAR Peptide Induces Anti-Inflammatory Therapeutic Responses.
    Paidi RK; Jana M; Mishra RK; Dutta D; Pahan K
    J Immunol; 2021 Nov; 207(10):2521-2533. PubMed ID: 34645689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiling Antibody Response Patterns in COVID-19: Spike S1-Reactive IgA Signature in the Evolution of SARS-CoV-2 Infection.
    Siracusano G; Brombin C; Pastori C; Cugnata F; Noviello M; Tassi E; Princi D; Cantoni D; Malnati MS; Maugeri N; Bozzi C; Saretto G; Clementi N; Mancini N; Uberti-Foppa C; Temperton N; Bonini C; Di Serio C; Lopalco L
    Front Immunol; 2021; 12():772239. PubMed ID: 34804064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant SARS-CoV-2 Spike Protein and Its Receptor Binding Domain Stimulate Release of Different Pro-Inflammatory Mediators via Activation of Distinct Receptors on Human Microglia Cells.
    Tsilioni I; Theoharides TC
    Mol Neurobiol; 2023 Nov; 60(11):6704-6714. PubMed ID: 37477768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and characterization of two equine formulations towards SARS-CoV-2 proteins for the potential treatment of COVID-19.
    León G; Herrera M; Vargas M; Arguedas M; Sánchez A; Segura Á; Gómez A; Solano G; Corrales-Aguilar E; Risner K; Narayanan A; Bailey C; Villalta M; Hernández A; Sánchez A; Cordero D; Solano D; Durán G; Segura E; Cerdas M; Umaña D; Moscoso E; Estrada R; Gutiérrez J; Méndez M; Castillo AC; Sánchez L; Sánchez R; Gutiérrez JM; Díaz C; Alape A
    Sci Rep; 2021 May; 11(1):9825. PubMed ID: 33972631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The S1 Subunit of the SARS-CoV-2 Spike Protein Activates Human Monocytes to Produce Cytokines Linked to COVID-19: Relevance to Galectin-3.
    Schroeder JT; Bieneman AP
    Front Immunol; 2022; 13():831763. PubMed ID: 35392091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.